K. Tetsuka

发表

Recent Progress in Hepatocyte Culture Models and Their Application to the Assessment of Drug Metabolism, Transport, and Toxicity in Drug Discovery: The Value of Tissue Engineering for the Successful Development of a Microphysiological System.

Kenji Tabata, K. Tabata, K. Tetsuka, 2017, Journal of pharmaceutical sciences.

Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).

K. Hillgren, D. Mendrick, A. Baudy, 2022, ALTEX.

Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-β1 and β-glycerophosphate

M. Obinata, T. Terasaki, H. Iizasa, 2002 .

mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a New in vitro BBB Model for Drug Targeting

M. Obinata, H. Takanaga, T. Terasaki, 2000, Journal of drug targeting.

Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.

K. Tetsuka, Masato Ohbuchi, S. Yamazaki, 2020, Biological & pharmaceutical bulletin.

DMD056291 885..889

Yuichiro Sato, A. Miyashita, K. Tetsuka, 2014 .

Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene

M. Obinata, H. Takanaga, T. Terasaki, 2000, AAPS PharmSci.

Quantitative Prediction of Human Intestinal Glucuronidation Effects on Intestinal Availability of UDP-Glucuronosyltransferase Substrates Using In Vitro Data

K. Tetsuka, K. Yamano, K. Hosoya, 2012, Drug Metabolism and Disposition.

Modelling and Prevention of Acute Kidney Injury through Ischemia and Reperfusion in a Combined Human Renal Proximal Tubule/Blood Vessel-on-a-Chip

T. Hankemeier, P. Vulto, H. Lanz, 2021, Kidney360.

Acidic amino acid transport characteristics of a newly developed conditionally immortalized rat type 2 astrocyte cell line (TR-AST).

M. Obinata, H. Takanaga, T. Terasaki, 2001, Cell structure and function.

Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys

K. Tabata, K. Tetsuka, K. Yamano, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

Species differences in sinusoidal and canalicular efflux transport of mycophenolic acid 7-O-glucuronide in sandwich-cultured hepatocytes

K. Tetsuka, Kouichi Tamura, Kazuhiro Tetsuka, 2014, Pharmacology research & perspectives.

Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.

K. Tetsuka, N. Gerst, J. Masters, 2014, Drug metabolism and pharmacokinetics.

Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-beta1 and beta-glycerophosphate.

M. Obinata, T. Terasaki, H. Iizasa, 2002, European journal of cell biology.

The l‐isomer‐selective transport of aspartic acid is mediated by ASCT2 at the blood–brain barrier

H. Takanaga, T. Terasaki, S. Ohtsuki, 2003, Journal of neurochemistry.

Optimized Methods for Targeted Peptide-Based Quantification of Human Uridine 5′-Diphosphate-Glucuronosyltransferases in Biological Specimens Using Liquid Chromatography–Tandem Mass Spectrometry

M. Nagata, Yuichiro Sato, A. Miyashita, 2014, Drug Metabolism and Disposition.

HDAC Inhibitors Restore the Capacity of Aged Mice to Respond to Haloperidol through Modulation of Histone Acetylation

J. Csernansky, Hongxin Dong, M. Matsumoto, 2014, Neuropsychopharmacology.

Quantitative prediction of intestinal glucuronidation of drugs in rats using in vitro metabolic clearance data.

K. Tetsuka, K. Yamano, T. Furukawa, 2012, Drug metabolism and pharmacokinetics.

Quantitative Prediction of Human Intestinal Glucuronidation Effects on Intestinal Availability of UDP-glucuronosyltranferase Substrates using in vitro data

K. Tetsuka, K. Yamano, K. Kadono, 2012 .